Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

Ola Lindèn Department of Oncology, Lund University Hospital, Lund, SwedenCorrespondence[email protected]

Lars Stenberg Department of Diagnostic Radiology, Lund University Hospital, Lund, Sweden

Elisabeth Kjellén Department of Oncology Lund, Sweden and Department of Radiation Sciences, Umeå University, Umeå, Sweden

References

Hof H, Welzel T, Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 2006; 29: 572–4
PubMed Web of Science ®Google Scholar
Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): Combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res 2004; 64: 5355–62
PubMed Web of Science ®Google Scholar
Thomlinson RH. Measurement and management of carcinoma of the breast. Clin Radiol 1982; 33: 481–93
PubMed Web of Science ®Google Scholar
Trinh QD, Cardinal E, Gallina A, Perrotte P, Saad F, Karakiewicz PI. Sunitinib relieves renal cell carcinoma spinal cord compression. Eur Urol 2007; 51: 1741–3
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date